BRAF and melanoma: We were initially surprised to observe a greater number of drug-tolerant ATG5-modified cells; however, functional genetic studies performed in BRAF(V600E) melanoma cell lines also showed that increased resistance—rather than increased cell death—occurred when mechanisms promoting autophagy were disrupted [33].